all - Opinion Summaries
Page 8 of 88
Showing Result 71 - 80 of 874
| Description | Date | Docket # |
|---|---|---|
In Re: Ethicon, Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an appeal of a merged inter partes reexamination, the USPTO Patent Trial and Appeal Board's decision affirming the examiner's obviousness rejection... |
01/03/2017 | 2015-1696 |
Lawton v. Takeda Pharm. Co.United States First Circuit
Civil Procedure, Drugs & BiotechIn a qui tam action under the False Claims Act (FCA), 31 U.S.C. section 3729 et seq., and the False Claims Acts of 28 different states and the... |
11/22/2016 | 16-1382 |
Medical Marijuana, Inc. v. ProjectCBD.comCalifornia Court of Appeal
Drugs & Biotech, Commercial Law, Media LawIn a commercial law action, arising out of a dispute between competing producers and intertwined online media outlets connected to the cannabidiol... |
11/21/2016 | D068523 |
In re: Nexium AntitrustUnited States First Circuit
Class Actions, Drugs & Biotech, Antitrust & Trade RegulationIn an appeal arising from the first pharmaceutical-settlement antitrust action tried before a jury since the Supreme Court's decision in FTC v.... |
11/21/2016 | 15-2005 |
Schueneman v. Arena Pharms., Inc.United States Ninth Circuit
Class Actions, Securities Law, Drugs & BiotechIn a putative securities class action in connection with defendants' public statements about their weight-loss drug, lorcaserin, the District Court's... |
10/26/2016 | 14-55633 |
Pasternack v. Lab. Corp.United States Second Circuit
Injury & Tort Law, Drugs & BiotechIn a negligence suit against drug testing companies for purportedly mishandling a random drug test, the District Court's dismissal of all claims is... |
10/06/2016 | 14-4101-cv |
Local 8 IBEW Retirement Plan & Trust v. Vertex Pharms., Inc.United States First Circuit
Class Actions, Securities Law, Health Law, Drugs & BiotechIn a securities fraud class action complaint brought by past and current employees of a pharmaceutical company that announced interim results of a... |
10/03/2016 | 15-2250 |
Mylan Pharmaceuticals Inc v. Warner Chilcott Pub. Ltd.United States Third Circuit
Drugs & Biotech, Antitrust & Trade RegulationIn a suit brought by generic drug manufactures against name-brand drug manufacturers of 'Doryx' the name-brand version of delayed-release doxycycline... |
09/28/2016 | 15-2236 |
In Re: Modafinil Antitrust LitigationUnited States Third Circuit
Class Actions, Drugs & Biotech, Antitrust & Trade RegulationIn a putative class of twenty-two large and sophisticated corporations, most of which have multi-million dollar claims, alleging a global conspiracy... |
09/13/2016 | 15-3475 |
UCB, Inc. v. Yeda Research and Development Co., Ltd.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an declaratory judgment requesting a declaration that plaintiff's Cimzia brand antibody does not infringe defendant's patent and that such patent... |
09/08/2016 | 2015-1957 |
Results 71 to 80 of 874